XBiotech

XBiotech

XBIT· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock -39.5% in FY2025

Sushma Shivaswamy is the CEO of XBiotech and was paid $571.0K in FY2025 (Dec).

Pay$100 in the stock at the end of FY21 → $22
CEO pay is from each XBiotech proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives3

See all
  1. 1John SimardFY2023
  2. 2Sushma ShivaswamyFY2025
  3. 3Angela HuFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

XBiotech paid its 2 named executives $816.4K in total in FY2025 (Dec). CEO Sushma Shivaswamy was paid $571.0K of that.

Name
Sushma ShivaswamyPh.D. Interim Chief Executive Officer & Chief Scientific OfficerNot disclosed
Angela HuDirector of Finance
John SimardFormer President & Chief Executive OfficerNot disclosedNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for XBiotech. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Board2

See all
  • Jan-Paul Waldin, Esq.Lead independent director · 6 yr on the boardIndependentAudit (Chair), Compensation (Chair), Nominating and Corporate Governance (Chair)—Paid as an executive
  • Peter Libby, M.D.Director · 5 yr on the boardIndependentAudit, Compensation, Nominating and Corporate Governance—Paid as an executive

The board of the latest proxy (FY2024).

Activity

Filings6

See all
Proxy statementDEF 14AOct 2, 2026FY2025
Annual report10-KMar 13, 2026FY2025
Proxy statementDEF 14AJul 7, 2025FY2024
Annual report10-KMar 18, 2025FY2024
Proxy statementDEF 14AMay 1, 2024FY2023
Annual report10-KMar 15, 2024FY2023